UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 3,314 Shares of Chemed Co. (NYSE:CHE)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Chemed Co. (NYSE:CHE - Free Report) by 7.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,920 shares of the company's stock after purchasing an additional 3,314 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.31% of Chemed worth $27,597,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CHE. SG Americas Securities LLC lifted its position in shares of Chemed by 422.9% during the 2nd quarter. SG Americas Securities LLC now owns 7,551 shares of the company's stock worth $4,097,000 after buying an additional 6,107 shares during the period. Harbor Capital Advisors Inc. lifted its holdings in shares of Chemed by 292.7% during the second quarter. Harbor Capital Advisors Inc. now owns 1,241 shares of the company's stock valued at $673,000 after acquiring an additional 925 shares during the period. Hsbc Holdings PLC boosted its stake in shares of Chemed by 110.0% in the 2nd quarter. Hsbc Holdings PLC now owns 10,638 shares of the company's stock valued at $5,801,000 after purchasing an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC bought a new stake in shares of Chemed in the 2nd quarter worth about $7,812,000. Finally, Quest Partners LLC increased its position in shares of Chemed by 634.3% during the 2nd quarter. Quest Partners LLC now owns 1,990 shares of the company's stock worth $1,080,000 after purchasing an additional 1,719 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Insider Activity at Chemed

In other news, Director George J. Walsh III sold 400 shares of the stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now owns 3,046 shares of the company's stock, valued at $1,819,893.62. This represents a 11.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business's stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $598.81, for a total transaction of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares in the company, valued at $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,845 shares of company stock worth $3,978,798 over the last ninety days. Company insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CHE. Royal Bank of Canada cut their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research report on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th.

Chemed Stock Performance

CHE traded down $14.11 during mid-day trading on Thursday, reaching $555.25. The stock had a trading volume of 40,488 shares, compared to its average volume of 85,520. The firm's fifty day simple moving average is $576.77 and its two-hundred day simple moving average is $565.09. The stock has a market capitalization of $8.36 billion, a P/E ratio of 28.79, a P/E/G ratio of 2.40 and a beta of 0.46. Chemed Co. has a 52 week low of $523.33 and a 52 week high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed's revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $5.32 EPS. As a group, analysts expect that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date is Monday, November 18th. Chemed's dividend payout ratio (DPR) is 10.11%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.